SIGA Technologies, Inc. (SIGA)
3.06
0.00 (0.00%)
USD |
NASDAQ |
Aug 28, 16:00
3.06
0.00 (0.00%)
Pre-Market: 20:00
SIGA Technologies Enterprise Value : 102.70M for Aug. 28, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| August 28, 2026 | 102.70M |
| August 27, 2026 | 102.70M |
| August 26, 2026 | 103.42M |
| August 25, 2026 | 101.26M |
| August 24, 2026 | 94.08M |
| August 21, 2026 | 101.26M |
| August 20, 2026 | 96.23M |
| August 19, 2026 | 106.29M |
| August 18, 2026 | 97.67M |
| August 17, 2026 | 93.36M |
| August 14, 2026 | 98.39M |
| August 13, 2026 | 89.77M |
| August 12, 2026 | 89.05M |
| August 11, 2026 | 89.77M |
| August 10, 2026 | 93.36M |
| August 07, 2026 | 101.98M |
| August 06, 2026 | 107.01M |
| August 05, 2026 | 109.16M |
| August 04, 2026 | 115.63M |
| August 03, 2026 | 113.47M |
| July 31, 2026 | 117.78M |
| July 30, 2026 | 116.35M |
| July 29, 2026 | 122.81M |
| July 28, 2026 | 122.81M |
| July 27, 2026 | 105.57M |
| Date | Value |
|---|---|
| July 24, 2026 | 106.29M |
| July 23, 2026 | 109.16M |
| July 22, 2026 | 126.41M |
| July 21, 2026 | 140.06M |
| July 20, 2026 | 132.87M |
| July 17, 2026 | 130.00M |
| July 16, 2026 | 138.62M |
| July 15, 2026 | 138.62M |
| July 14, 2026 | 128.56M |
| July 13, 2026 | 142.21M |
| July 10, 2026 | 140.78M |
| July 09, 2026 | 134.31M |
| July 08, 2026 | 137.18M |
| July 07, 2026 | 146.52M |
| July 06, 2026 | 152.27M |
| July 02, 2026 | 160.17M |
| July 01, 2026 | 150.11M |
| June 30, 2026 | 144.37M |
| June 29, 2026 | 114.00M |
| June 26, 2026 | 136.23M |
| June 25, 2026 | 138.39M |
| June 24, 2026 | 164.92M |
| June 23, 2026 | 163.49M |
| June 22, 2026 | 165.64M |
| June 18, 2026 | 164.92M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| ANI Pharmaceuticals, Inc. | 1.908B |
| Corcept Therapeutics, Inc. | 11.99B |
| Veru, Inc. | 21.65M |
| Johnson & Johnson | 673.78B |
| Eli Lilly & Co. | 1.152T |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 12.46M |
| Revenue (Quarterly) | 41.00M |
| Total Expenses (Quarterly) | 28.54M |
| EPS Diluted (Quarterly) | 0.1734 |
| Gross Profit Margin (Quarterly) | 57.17% |
| Profit Margin (Quarterly) | 30.40% |
| Earnings Yield | -1.29% |
| Normalized Earnings Yield | -1.294 |